Household accounts tied to Rep. Ro Khanna reported roughly $83,000 in purchases of health insurance giant ELV in February, according to newly filed congressional financial disclosures.
The transactions took place over a one-week period and were split between a smaller purchase by Khanna’s spouse and a significantly larger buy reported for a dependent. Combined, the filings indicate between $51,000 and $115,000 in total exposure added to Elevance Health Inc., one of the largest managed-care companies in the United States.
Elevance Health, which trades on the New York Stock Exchange and carries a market capitalization of about $64.4 billion, operates major Blue Cross Blue Shield plans in multiple states while also expanding its health services and pharmacy benefit operations. The stock recently traded around $291.63.
Congressional disclosure rules require lawmakers to report transactions in ranges rather than precise dollar amounts. Based on those ranges, the Khanna household purchases break down as follows:
- Feb. 17, 2026: Buy of ELV valued between $1,000 and $15,000 (spouse)
- Feb. 24, 2026: Buy of ELV valued between $50,000 and $100,000 (dependent)
Together, the filings place the estimated midpoint value of the trades at about $83,000.
A major insurer closely watched by investors
Elevance Health sits at the center of several major trends in U.S. healthcare finance. The company generates revenue through employer-sponsored health plans as well as government programs including Medicare Advantage and Medicaid managed care.
Investors tend to track three key indicators for the insurer: membership growth, reimbursement trends tied to federal health programs, and its medical cost ratio — a measure of how much of its premium revenue is spent on patient care.
Like many large managed-care companies, Elevance has also been expanding into care management, analytics, and pharmacy benefits services, which analysts view as a long-term diversification strategy beyond traditional insurance underwriting.
The company’s performance can be sensitive to policy shifts affecting Medicare Advantage payments, Medicaid redeterminations, and healthcare utilization trends — factors that frequently draw attention in Washington.
Congressional interest in ELV
Khanna is not alone on Capitol Hill in trading the insurer. Disclosure records show at least 20 lawmakers have reported transactions involving Elevance Health.
The California Democrat has been an active market participant over the course of his career, with more than 19,600 reported trades in congressional filings.
Khanna currently serves on the House Armed Services Committee and the House Oversight and Government Reform Committee, along with multiple subcommittees focused on cybersecurity, technology, and strategic competition with China.
Members of Congress are permitted to buy and sell individual stocks, though the STOCK Act requires public disclosure of transactions within 45 days. The law was designed to increase transparency and deter trading on nonpublic information.
Investors and transparency watchdogs routinely monitor these disclosures for patterns or sector concentration. Readers can track similar activity through the latest congressional trades reported across Capitol Hill.
For now, the February filings show the Khanna household increasing its exposure to one of the country’s largest health insurers during a period when managed-care stocks remain closely tied to federal healthcare spending trends.